Hga. Bouwer et al., Existing antilisterial immunity does not inhibit the development of a Listeria monocytogenes-specific primary cytotoxic T-lymphocyte response, INFEC IMMUN, 67(1), 1999, pp. 253-258
Infection of BALB/c mice with Listeria monocytogenes stimulates an antilist
erial immune response evident by the appearance of H2-K-d-restricted CD8(+)
cytotoxic T lymphocytes (CTLs) specific for the nanomer peptides amino aci
ds (aa) 91 to 99 of listeriolysin O (LLO 91-99) and aa 217 to 225 of the p6
0 molecule (p60 217-225), We have introduced point mutations at anchor resi
dues within LLO 91-99 (92F) or p60 217-225 (218F), and BALB/c mice infected
with L. monocytogenes strains containing these point mutations do not deve
lop CTLs specific for LLO 91-99 or p60 217-225, respectively. We have used
these strains to test whether primary CTL responses against L, monocytogene
s-derived determinants can be stimulated within an environment of existing
antilisterial immunity. We found that the development of a primary L, monoc
ytogenes-specific CTL response is not altered by existing immunity to L. mo
nocytogenes, For example, primary immunization with the p60 218F strain of
L, monocytogenes followed by a secondary immunization with wild-type L. mon
ocytogenes results in stimulation of p60 217-225-specific CTLs at primary r
esponse levels and LLO 91-99-specific effecters at levels consistent with a
memory CTL response. Similarly, primary immunization with the 92F strain o
f L. monocytogenes followed by a secondary immunization with wild-type L, m
onocytogenes results in stimulation of LLO 91-99-specific CTLs at primary r
esponse levels and p60 217-225-specific effecters at levels consistent with
a memory CTL response. These results provide additional support for the us
e of L. monocytogenes as a recombinant vaccine vector and show that antivec
tor immunity does not inhibit the development of a primary CTL response whe
n the epitope is delivered by L. monocytogenes as the vaccine strain.